Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Tru2u Tirzepatide Review: Cost, a Combined GLP Squared Injection & Honest Verdict (2026)

An honest 2026 review of Tru2u tirzepatide — both injectable and oral options plus a combined GLP Squared injection, but no named pharmacy or LegitScript seal.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

yourEra

Transparent compounded tirzepatide with both molecules and a broad longevity menu, shipped nationwide — priced in the mid-market.

From $159/mo

Check yourEra availability

Tru2u is a US direct-to-consumer telehealth and wellness store offering compounded GLP-1 weight-loss therapy alongside hair, skincare, and supplement lines, with a distinctive combined GLP Squared injection option. Every fact here comes from the company's own published program.

What Tru2u is

Tru2u is a US direct-to-consumer telehealth and wellness store, offering compounded semaglutide and tirzepatide plus a combined GLP Squared injection, in both injectable and oral tablet forms.

§ Tru2u — Combined Injection, No Accreditation

ItemDetail
Tirzepatide$345/mo
GLP Squared injectionCombined semaglutide+tirzepatide option
LegitScriptNot shown
No compounding pharmacy named, no LegitScript seal shown.

What Tru2u costs

Tirzepatide runs $345/month — higher than many compounded competitors — shown transparently upfront with free shipping.

The brand-vs-compounded question

Tru2u dispenses compounded semaglutide and tirzepatide. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Tru2u's real strengths is a combined GLP Squared injection option, both injectable and oral GLP-1 tablet forms, and transparent upfront monthly pricing with free shipping. The trade-offs: no compounding pharmacy is publicly named and no LegitScript seal is shown, tirzepatide at $345/month runs above many compounded competitors, and states served aren't published — the site states US-only availability. As with any GLP-1 program, and especially one without a visible accreditation badge, ask directly about pharmacy sourcing before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Tru2u's combined GLP Squared option and transparent pricing are real positives, but the missing LegitScript badge and unnamed pharmacy are worth asking about directly, especially given the above-median price. For a provider with a genuinely verified LegitScript seal, compare it against Tryozi or Ondra Health. If price is your priority, VirtualCare2Go offers same-day visits but runs even higher. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

What is Tru2u's GLP Squared injection?

A combined injection option pairing semaglutide and tirzepatide.

How much does tirzepatide cost through Tru2u?

$345/month, above many compounded competitors.

Is Tru2u LegitScript certified?

No seal is shown.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.